Potential Effects of the MIND Diet in the Management of Neurological Diseases

Abstract

Today, the significant increase in the prevalence of neurological diseases, parallel to the increase in the elderly population, is noteworthy. Disability, cognitive impairment, and progressive, debilitating symptoms caused by neurological diseases such as Alzheimer's disease and Parkinson's disease pose a serious burden on both patients and caregivers. Owing to their impact on society, there is a need to develop effective strategies for the prevention and treatment of these diseases. Nutritional lifestyle interventions are important approaches that may have an impact on neurological disease development and progression. The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, a combination of the Mediterranean diet and the Dietary Approaches to Stop Hypertension (DASH) eating patterns, emphasizes more green leafy vegetables, berries, olive oil, fish, whole grains, nuts, beans, poultry, and less red meat, sugar, and saturated fat. Studies have reported that compliance with the MIND diet is associated with cognitive benefits and may be an effective strategy to reduce the risk of Alzheimer's disease and dementia. The MIND diet may have positive effects on neurological diseases through mechanisms such as establishing a balanced brain-gut microbiota axis, reducing oxidative stress and inflammation, and improving metabolic risk factors. However, the underlying molecular mechanisms remain to be elucidated. In this review, the relationship between the MIND diet and neurological diseases and the possible mechanisms mediating this relationship are examined.

Keywords

• Alzheimer’s disease
• dietary therapy
• MIND diet
• neurological diseases

Nörolojik Hastalıkların Yönetiminde MIND Diyetinin Potansiyel Etkileri

Abstract

Günümüzde yaşlı nüfus artışına paralel olarak nörolojik hastalıkların prevalansında görülen belirgin artış dikkat çekmektedir. Alzheimer, Parkinson hastalığı gibi nörolojik hastalıkların neden olduğu kısıtlılık hali, bilişsel bozukluk, ilerleyici, güçten düşürücü semptomlar hem hasta hem de bakım vericiler üzerinde ciddi bir yük oluşturur. Toplum üzerindeki etkileri nedeniyle bu hastalıkların önlenmesi ve tedavisine yönelik etkili stratejiler geliştirilmesine ihtiyaç duyulmaktadır. Beslenmeye yönelik yaşam tarzı müdahaleleri nörolojik hastalık gelişimi ve ilerlemesi üzerinde etkili olabilecek önemli bir yaklaşımdır. Akdeniz diyeti ve Hipertansiyonu Durdurmaya Yönelik Diyet Yaklaşımları (DASH) beslenme düzenlerinin birleşimi olan Nörodejeneratif Gecikmeye Yönelik Akdeniz-DASH Müdahalesi (MIND) diyeti yeşil yapraklı sebzeler, üzümsü meyveler, zeytinyağı, balık, tam tahıllar, kuruyemiş, kurubaklagiller, kümes hayvanlarının daha fazla, kırmızı et, şeker ve doymuş yağların daha az tüketilmesini vurgulamaktadır. Yapılan çalışmalarda MIND diyetine uyumun bilişsel faydalarla ilişkili olduğu ve Alzheimer hastalığı ve demans riskini azaltmak için etkili bir strateji olabileceği bildirilmiştir. Nörolojik hastalıklarda MIND diyetinin dengeli beyin-bağırsak mikrobiyota ekseni kurulması, oksidatif stres ve inflamasyonun azaltılması, metabolik risk faktörlerinde iyileşme sağlanması gibi mekanizmalarla olumlu etkiler sağladığı düşünülmektedir. Bununla birlikte altta yatan moleküler mekanizmalar halen aydınlatılmayı beklemektedir. Bu derlemede MIND diyetinin nörolojik hastalıklarla ilişkisi ve bu ilişkiye aracılık eden olası mekanizmalar incelenecektir.

Keywords

• Alzheimer hastalığı
• diyet terapi
• MIND diyeti
• nörolojik hastalıklar

Supporting Institution

Yok

Thanks

Yok

References

1. Mahan KL, Raymond JL. Krause's Food&The Nutrition Care Process. 14th Edition. Canada: Elsevier Inc; 2017. 813 p.
2. Morén C, de Souza RM, Giraldo DM, Uff C. Antioxidant therapeutic strategies in neurodegenerative diseases. Int J Mol Sci. 2022 Aug;23(16):9328. DOI: 10.3390/ijms23169328.
3. Aderinto N, Olatunji G, Abdulbasit M, Olajide TN, Kokori E. Examining the efficacy of the Mediterranean-DASH diet intervention for neurodegenerative delay in mitigating cognitive decline. Egypt J Neurol Psychiatry Neurosurg. 2023 Nov;59(145):1-18. DOI: 10.1186/s41983-023-00752-1.
4. Lai R, Li B, Bishnoi R. P-tau217 as a reliable blood-based marker of Alzheimer’s disease. Biomedicines. 2024 Aug;12(8):1836. DOI: 10.3390/biomedicines12081836.
5. Morris MC, Tangney CC, Wang Y, Sacks FM, Barnes LL, Bennett DA, et al. MIND diet slows cognitive decline with aging. Alzheimers Dement. 2015 Sep;11(9):1015–22. DOI: 10.1016/j.jalz.2015.04.011.
6. Sinyor B, Mineo J, Ochner C. Alzheimer's disease, inflammation, and the role of antioxidants. J Alzheimers Dis Rep. 2020 Jun;4(1):175–83. DOI: 10.3233/ADR-200171.
7. de Crom TOE, Mooldijk SS, Ikram MK, Ikram MA, Voortman T. MIND diet and the risk of dementia: a population-based study. Alzheimer's research&therapy. 2022 Jan;14(1):8. DOI: 10.1186/s13195-022-00957-1.
8. Noormohammadi M, Ghorbani Z, Naser Moghadasi A, Saeedirad Z, Shahemi S, Ghanaatgar M, et al. MIND diet adherence might be associated with a reduced odds of multiple sclerosis: results from a case-control Study. Neurol Ther. 2022 Mar;11(1):397–412. DOI: 10.1007/s40120-022-00325-z.

9. van Soest AP, Beers S, van de Rest O, de Groot LC. The Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) diet for the aging brain: a systematic review. Adv Nutr. 2024 Mar;15(3):100184. DOI: 10.1016/j.advnut.2024.100184.
10. Askarpour M, Yarizadeh H, Sheikhi A, Khorsha F, Mirzaei K. Associations between adherence to MIND diet and severity, duration and frequency of migraine headaches among migraine patients. BMC Res Notes. 2020 Jul;13(1):341. DOI: 10.1186/s13104-020-05181-4.
11. Agarwal P, Wang Y, Buchman AS, Holland TM, Bennett DA, Morris MC. MIND diet associated with reduced incidence and delayed progression of ParkinsonismA in old age. J Nutr Health Aging. 2018;22(10):1211–5. DOI: 10.1007/s12603-018-1094-5.
12. Fox DJ, Park SJ, Mischley LK. Comparison of associations between MIND and Mediterranean diet scores with patient-reported outcomes in Parkinson's disease. Nutrients. 2022 Dec;14(23):5185. DOI: 10.3390/nu14235185.
13. Metcalfe-Roach A, Yu AC, Golz E, Cirstea M, Sundvick K, Kliger D, et al. MIND and Mediterranean diets associated with later onset of Parkinson's disease. Mov Disord. 2021 Apr;36(4):977–84. DOI: 10.1002/mds.28464.
14. Zare S, Eftekhari MH, Arjmand G, Zare M. Adherence to Mediterranean-Dash Intervention for Neurodegenerative Delay (MIND) dietary pattern in elderly with type 2 diabetes and the correlation with cognitive functions and metabolic profile. Int J Nutr Sci. 2023 Mar;8(2):102-8. DOI: 10.30476/ijns.2023.97692.
15. Morris MC, Tangney CC, Wang Y, Sacks FM, Bennett DA, Aggarwal NT. MIND diet associated with reduced incidence of Alzheimer’s disease. Alzheimers Dement. 2015 Sep;11:1007–14. DOI: 10.1016/j.jalz.2014.11.009.
16. Atabilen B, Kilif MS, Coşkun SN, Ceyhan GH, Cin K, Akdevelioğlu Y. Turkish adaptation, validity and reliability study of the MIND diet scale for delaying neurodegeneration. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi. 2024 Sep;13(3):1030-7. DOI: 10.37989/gumussagbil.1506595.
17. Merlo G, Bachtel G, Sugden SG. Gut microbiota, nutrition, and mental health. Front Nutr. 2024 Feb;11:1337889. DOI: 10.3389/fnut.2024.1337889.
18. Golmohammadi M, Attari VE, Salimi Y, Saed L, Nachvak SM, Samadi M. The effect of MIND diet on sleep status, mental health, and serum level of BDNF in overweight/obese diabetic women with insomnia: a randomized controlled trial. SciRep. 2025 Mar;15(1):8237. DOI: 10.1038/s41598-025-91389-y.
19. Birk R. Nutrigenetics of antioxidant enzymes and micronutrient needs in the context of viral infections. Nutr Res Rev. 2021 Dec;34(2):174-84. DOI: 10.1017/S0954422420000244.
20. Agarwal P, Barnes LL, Dhana K, Liu X, Zhang Y, Beck T, et al. Association of MIND diet with cognitive decline among Black and White older adults. Alzheimers Dement. 2024 Aug;20(12):8461-9. DOI: 10.1002/alz.14277.
21. Arjmand G, Abbas-Zadeh M, Eftekhari MH. Effect of MIND diet intervention on cognitive performance and brain structure in healthy obese women: a randomized controlled trial. SciRep. 2022 Feb;12:2871. DOI: 10.1038/s41598-021-04258-9.
22. Navarrete-Pérez A, Gómez-Melero S, Escribano BM, Galvao-Carmona A, Conde-Gavilán C, Peña-Toledo MÁ, et al. MIND diet impact on multiple sclerosis patients: biochemical changes after nutritional intervention. Int J Mol Sci. 2024 Sep;25(18):10009. DOI: 10.3390/ijms251810009.
23. Ardekani AM, Vahdat S, Hojati A, Moradi H, Tousi AZ, Ebrahimzadeh F, et al. Evaluating the association between the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, mental health, and cardio-metabolic risk factors among individuals with obesity. BMC Endocr Disord. 2023 Feb;23(1):29. DOI: 10.1186/s12902-023-01284-8.
24. Dhana K, James BD, Agarwal P, Aggarwal NT, Cherian LJ, Leurgans SE, et al. MIND diet, common brain pathologies, and cognition in community-dwelling older adults. J Alzheimers Dis. 2021;83(2):683–92. DOI: 10.3233/JAD-210107.
25. Chen H, Dunk MM, Wang B, Zhao M, Shen J, Zong G, et al. Associations of the Mediterranean-DASH Intervention for Neurodegenerative Delay diet with brain structural markers and their changes. Alzheimers Dement. 2024 Feb;20(2):1190–1200. DOI: 10.1002/alz.13521.
26. Urbano T, Filippini T, Malavolti M, Fustinoni S, Michalke B, Wise LA, et al. Adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet and exposure to selenium species: A cross-sectional study. Nutr Res. 2024 Feb;122:44–54. DOI: 10.1016/j.nutres.2023.12.002.
27. Turck D, Bohn T, Castenmiller J, Henauw SD, Hirsch‐Ernst KI, Knutsen HK. Scientific opinion on the tolerable upper intake level for selenium. EFSA Journal. 2023 Jan;21. DOI: 10.2903/j.efsa.2023.7704.
28. Nucci D, Sommariva A, Degoni LM, Gallo G, Mancarella M, Natarelli F, et al. Association between Mediterranean diet and dementia and Alzheimer disease: a systematic review with meta-analysis. Aging Clin Exp Res. 2024 Mar;36(1):77. DOI: 10.1007/s40520-024-02718-6.
29. Barnes LL, Dhana K, Liu X, Carey VJ, Ventrelle J, Johnson K, et al. Trial of the MIND diet for prevention of cognitive decline in older persons. NEJM. 2023 Aug;389(7):602–11. DOI: 10.1056/NEJMoa2302368.
30. Sawyer RP, Blair J, Shatz R, Manly JJ, Judd SE. Association of adherence to a MIND-style diet with the risk of cognitive impairment and decline in the REGARDS cohort. Neurology. 2024 Oct;103(8):e209817. DOI: 10.1212/WNL.0000000000209817.
31. Winiarska-Mieczan A, Baranowska-Wójcik E, Kwiecień M, Grela ER, Szwajgier D, Kwiatkowska K, et al. The role of dietary antioxidants in the pathogenesis of neurodegenerative diseases and their impact on cerebral oxidoreductive balance. Nutrients. 2020 Feb;12(2):435. DOI: 10.3390/nu12020435.
32. Pan MH, Lai CS, Ho CT. Anti-inflammatory activity of natural dietary flavonoids. Food Funct. 2010 Oct;1(1):15-31. DOI: 10.1039/c0fo00103a.
33. Chen H, Dhana K, Huang Y, Huang L, Tao Y, Liu X, et al. Association of the Mediterranean Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) diet with the risk of dementia. JAMA psychiatry. 2023 Jun;80(6):630–8. DOI: 10.1001/jamapsychiatry.2023.0800.
34. Huang L, Tao Y, Chen H, Chen X, Shen J, Zhao C, et al. Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) diet and cognitive function and its decline: a prospective study and meta-analysis of cohort studies. Am J Clin Nutr. 2023 Jul;118(1):174–82. DOI: 10.1016/j.ajcnut.2023.04.025.
35. Hantikainen E, Trolle Lagerros Y, Ye W, Serafini M, Adami HO, Bellocco R, et al. Dietary antioxidants and the risk of Parkinson disease: The Swedish National March Cohort. Neurology. 2021 Feb;96(6):e895–e903. DOI: 10.1212/WNL.0000000000011373.
36. Katz Sand IB, Fitzgerald KC, Gu Y, Brandstadter R, Riley CS, Buyukturkoglu K, et al. Dietary factors and MRI metrics in early multiple sclerosis. Mult Scler Relat Disord. 2021 Aug;53:103031. DOI: 10.1016/j.msard.2021.103031.
37. Caprio M, Moriconi E, Camajani E, Feraco A, Marzolla V, Vitiello L, et al. Very-low-calorie ketogenic diet vs hypocaloric balanced diet in the prevention of high-frequency episodic migraine: the EMIKETO randomized, controlled trial. J Transl Med. 2023 Oct;21(1):692. DOI: 10.1186/s12967-023-04561-1.
38. Arab A, Khorvash F, Kazemi M, Heidari Z, Askari G. Effects of the Dietary Approaches to Stop Hypertension (DASH) diet on clinical, quality of life and mental health outcomes in women with migraine: a randomised controlled trial. Br J Nutr. 2022 Oct;128(8):1535–44. DOI: 10.1017/S000711452100444X.